All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Asia EquityAsia IPOs

Harbour BioMed sets ball rolling for Hong Kong IPO

biopharma_stocks_adobe_575x375.jpg

Chinese biotechnology start-up HBM Holdings has filed for approval to float on Hong Kong’s stock exchange.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree